Safety and effectiveness of angiotensin receptor-neprilysin inhibitors in patients with heart failure with preserved ejection fraction (ARNI-PRESERVED study).

Back

ACVC Premium Access

Safety and effectiveness of angiotensin receptor-neprilysin inhibitors in patients with heart failure with preserved ejection fraction (ARNI-PRESERVED study).

Session: e-Posters session

Topic: Pharmacotherapy

Speaker: Doctor P. Jariwala (Hyderabad, IN)

Event: ESC Acute CardioVascular Care 2022

Congress Presentation

Add to my library

About the speaker

Doctor Pankaj Jariwala

Yashoda Hospital, Hyderabad (India)

1 presentation

0 follower

90 more presentations in this session

Time is kidney: relation between pain-to-balloon time and acute kidney injury among ST segment elevation myocardial infarction patients undergoing primary percutaneous intervention

Speaker: Doctor D. Zahler (Tel Aviv, IL)

Access

Abstract

Slides

Clinical utility of the SCAI classification in cardiogenic shock patients of any etiology treated by a multidisciplinary team.

Speaker: Miss S. Lozano Jimenez (Majadahonda, ES)

Access

Abstract

Slides

Heart failure correction in patients with chronic renocardiac syndrome

Speaker: Mr A. Demikhov (Sumy, UA)

Access

Abstract

Slides

Features of vascular motor endothelial function in hypertensive patients with chronic heart failure

Speaker: Mr A. Demikhov (Sumy, UA)

Access

Abstract

Slides

Correlation of cholesterol efflux capacity with femoral and carotid plaque volume measured by sonographic 3D plaque volumetry

Speaker: Doctor M. Noflatscher (Innsbruck, AT)

Access

Abstract

Slides

Access the full session

e-Posters session

Speakers: Doctor P. Jariwala, Doctor D. Zahler, Miss S. Lozano Jimenez, Mr A. Demikhov, Mr A. Demikhov...

Access

About the event

ESC Acute CardioVascular Care 2022

18 March - 19 March 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources